Chien Wen Tseng
Affiliation: University of Hawaii
- Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized studyChien Wen Tseng
Department of Family Medicine and Community Health, University of Hawaii John A Burns School of Medicine, 677 Ala Moana Blvd, Ste 815, Honolulu, HI, 96813, USA
BMC Health Serv Res 16:499. 2016..All adult primary care physicians in Hawaii were offered the Prescribing Guide, and providers who enrolled received a link to the website and regular hardcopy updates...
- Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) StudyAndrew J Karter
Division of Research, Kaiser Permanente, Oakland, CA, USA
BMC Public Health 7:308. 2007..Our understanding of social disparities in diabetes-related health behaviors is incomplete. The purpose of this study was to determine if having less education is associated with poorer diabetes-related health behaviors...
- Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD StudyJulie A Schmittdiel
Division of Research, Kaiser Permanente, Oakland, CA, USA
BMC Health Serv Res 10:164. 2010....
- Health information technology and physicians' knowledge of drug costsChien Wen Tseng
Department of Family Medicine and Community Health, University of Hawaii, Honolulu, 96789, USA
Am J Manag Care 16:e105-10. 2010..To examine whether physicians' use of information technology (IT) was associated with better knowledge of drug costs...
- Elderly patients' knowledge of drug benefit caps and communication with providers about exceeding capsChien Wen Tseng
Department of Family Medicine and Community Health, University of Hawaii, Pacific Health Research Institute, 700 Bishop St, Ste 900, Honolulu, HI 96813, USA
J Am Geriatr Soc 57:848-54. 2009..Because beneficiaries who have such gaps must pay all drug costs, an accurate knowledge of gap thresholds and communication with providers about exceeding caps is important for elderly persons to manage out-of-pocket drug costs...
- Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes StudyChien Wen Tseng
Pacific Health Research Institute, 846 S Hotel St, 303, Honolulu, HI 96813, USA
Diabetes Care 31:261-6. 2008..To examine racial/ethnic and economic variation in cost-related medication underuse among insured adults with diabetes...
- Elderly patients' preferences and experiences with providers in managing their drug costsChien Wen Tseng
Department of Family Medicine and Community Health, University of Hawaii, Honolulu, Hawaii, USA
J Am Geriatr Soc 55:1974-80. 2007..To determine whether elderly patients with high drug expenditures want and receive providers' help in managing drug costs...
- Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patientsChien Wen Tseng
Department of Family Practice and Community Health, University of Hawaii, and Pacific Health Research Institute, Honolulu, USA
JAMA 290:222-7. 2003..Annual dollar limits, or "caps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of several proposals for a national Medicare drug benefit...
- Identifying widely covered drugs and drug coverage variation among Medicare part D formulariesChien Wen Tseng
Department of Family Medicine and Community Health, John A Burns School of Medicine at University of Hawaii, Honolulu, USA
JAMA 297:2596-602. 2007..Clinicians can find it difficult to know which drugs are covered for their Medicare patients because formularies vary widely among Medicare Part D plans and many states have 50 or more such plans...
- Physicians' willingness and barriers to considering cost when prescribingChien Wen Tseng
Hawaii Med J 65:318, 320-1. 2006..Insurers can help physicians by providing easy access to drug coverage information at the point of prescribing...
- Effect of generic-only drug benefits on seniors' medication use and financial burdenChien Wen Tseng
Department of Family Medicine and Community Health, University of Hawaii, c o PHRI 846 S Hotel Street, Honolulu, HI 96813, USA
Am J Manag Care 12:525-32. 2006..Generic-only drug benefits are a way to provide some coverage, as opposed to no coverage...
- Well-child care visits and risk of ambulatory care-sensitive hospitalizationsJeffrey O Tom
Kaiser Permanente Center for Health Research, Hawaii, 501 Alakawa St, Ste 201, Honolulu, HI96817
Am J Manag Care 19:354-60. 2013..To determine if poor well-child care (WCC) visit adherence is associated with increased risk for Ambulatory Care-Sensitive Hospitalizations (ACSHs) among young children in an integrated healthcare delivery system...
- When patients cannot afford their medicationsChien Wen Tseng
University of Hawaii, John A Burns School of Medicine, Dept of Family Medicine and Community Health, Mililani, USA
Am Fam Physician 70:605-6, 608. 2004
- Comparison of potentially preventable hospitalizations related to diabetes among Native Hawaiian, Chinese, Filipino, and Japanese elderly compared with whites, Hawai'i, December 2006-December 2010Tetine L Sentell
Office of Public Health Studies, University of Hawai i at Manoa, John A Burns School of Medicine, Honolulu, HI 96822, USA
Prev Chronic Dis 10:E123. 2013..We examined racial/ethnic differences in diabetes-related potentially preventable hospitalizations (DRPH) among people aged 65 years or older for Japanese, Chinese, Filipinos, Native Hawaiians, and whites...
- Missed well-child care visits, low continuity of care, and risk of ambulatory care-sensitive hospitalizations in young childrenJeffrey O Tom
Kaiser Center for Health Research Hawaii, 501 Alakawa Street, Honolulu, HI 96817, USA
Arch Pediatr Adolesc Med 164:1052-8. 2010....
- Medicare calibration of the clinically detailed risk information system for costKanika Kapur
University of Hawaii, USA
Health Care Financ Rev 25:37-54. 2003..This minimizes incentives to game the system by entering multiple related codes for the same condition. The R2 for the CD-RISC model is 11 percent...
- Six strategies to identify and assist patients burdened by out-of-pocket prescription costsG Caleb Alexander
Robert Wood Johnson Clinical Scholars Program, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL 60637, USA
Cleve Clin J Med 71:433-7. 2004..Many patients find that their out-of-pocket costs of medications are burdensome. Physicians can help, first by remembering to ask about the problem, and then by applying simple strategies to limit the patient's costs...
- Barriers to patient-physician communication about out-of-pocket costsG Caleb Alexander
Robert Wood Johnson Clinical Scholars Program, University of Chicago, IL 60637, USA
J Gen Intern Med 19:856-60. 2004..Though many patients and physicians believe that they should discuss out-of-pocket costs, research suggests that they infrequently do...
- Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverageChien Wen Tseng
University of Hawaii Department of Family Practice and Community Health, Honolulu, and UCLA Department of Medicine, Los Angeles, Calif
JAMA 292:952-60. 2004....
- Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes studyAndrew J Karter
Division of Research, Kaiser Permanente, Oakland, Calif, and Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, USA
Am J Public Health 98:365-70. 2008..We assessed educational disparities in smoking rates among adults with diabetes in managed care settings...
- Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) StudySusan L Johnson
Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, 48109, USA
Diabetes Care 29:1733-8. 2006..We examined factors associated with screening for albuminuria and initiation of ACE inhibitor or angiotensin receptor blocker (ARB) treatment in diabetic patients...